Stuart T. Haines: Pharmacist-Led Warfarin Management Improves Therapeutic Control in HeartMate 3 LVAD Patients
Stuart T. Haines, Editor-in-Chief JACCP, Professor and Director of Professional Development at University of Mississippi School of Pharmacy, shared on LinkedIn about a recent article by Bailey M. Colvin et al, published in Journal of the American College of Clinical Pharmacy, adding:
”The evidence for pharmacist-managed anticoagulation in patients just got a lot stronger.
A new study published in the Journal of the American College of Clinical Pharmacy – the largest multicenter cohort focused exclusively on LVAD patients – found that pharmacist-led warfarin management achieved a mean time-in-therapeutic range (TTR) of 65.6% versus 45.8% in patients managed by nonpharmacist clinicians.
That near-20-point advantage held after multivariable adjustment and came with no significant increase in clinically significant bleeding.
This fills a real evidence gap.
Prior studies in LVAD populations were small, single-center, and often included older device generations.
This study’s multicenter design and exclusive focus on the HeartMate 3 LVAD reflect current clinical practice – and the results strongly support the key role that pharmacists can play in the care of this very complex patient population under collaborative practice agreements.
Congratulations to authors Bailey Colvin, PharmD, BCCP, Lauren Kunkel, PharmD, BCCP, and the entire investigative team for this important contribution to the literature!”
Title: Comparing Pharmacist-Managed Warfarin Versus Usual Care in HeartMate 3 Patients: A Multicenter Retrospective Observational Study
Authors: Bailey M. Colvin, Lauren Kunkel, Abby Bauer, April S. Britt, Christine Cadiz, Paige Carrigan, Teresa Chu, Kathleen Faulkenberg, Corinn Floyd, Ian Hollis, Mackenzie Payne, Amanda Prosenjak, Sijin Wen, Jordan C. Wilkie, Meiling Zheng, Kazuhiko Kido
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 6, 2026, 04:07Moussa Zein Aldine: Acute Coronary Syndrome Every Minute Matters
-
Oct 6, 2026, 03:13Patrick Taylor: Glow Stack Trend What the Evidence Really Shows
-
Oct 6, 2026, 02:59Preventing Hospital Associated Venous Thromboembolism – Thrombosis Canada
-
Oct 6, 2026, 02:42Treatment of Iron Deficiency With and Without Anemia – American Society of Hematology
-
Oct 6, 2026, 02:36Mouna Sassi: When Clinical and Laboratory Perspectives Meet in Thrombosis Care
-
Oct 6, 2026, 02:35Lucia Stefanini: Platelet Dysfunction and Oxidized Phospholipids in MASLD
-
Oct 6, 2026, 02:18Pablo Corral: Association of Lp(a) With Coronary Atherosclerosis and CV Events
-
Oct 5, 2026, 22:55Steve Humphreys: A Big Thank You to BSHT for Providing Me With a Recent Skills Exchange Award
-
Oct 5, 2026, 22:52William McKeown: Great to Be in Istanbul for the Opening of the EHC 2026